chr15-82989133-A-G
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_031452.4(RAMAC):āc.115A>Gā(p.Ile39Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000178 in 1,461,562 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 11/15 in silico tools predict a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Consequence
NM_031452.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
RAMAC | NM_031452.4 | c.115A>G | p.Ile39Val | missense_variant | 3/4 | ENST00000304191.4 | NP_113640.1 | |
C15orf40 | NM_001160116.2 | c.391T>C | p.Leu131Leu | synonymous_variant | 4/4 | NP_001153588.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
RAMAC | ENST00000304191.4 | c.115A>G | p.Ile39Val | missense_variant | 3/4 | 1 | NM_031452.4 | ENSP00000307181.3 |
Frequencies
GnomAD3 genomes Cov.: 31
GnomAD3 exomes AF: 0.0000319 AC: 8AN: 250706Hom.: 0 AF XY: 0.0000442 AC XY: 6AN XY: 135624
GnomAD4 exome AF: 0.0000178 AC: 26AN: 1461562Hom.: 0 Cov.: 31 AF XY: 0.0000193 AC XY: 14AN XY: 727104
GnomAD4 genome Cov.: 31
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 07, 2024 | The c.115A>G (p.I39V) alteration is located in exon 3 (coding exon 1) of the FAM103A1 gene. This alteration results from a A to G substitution at nucleotide position 115, causing the isoleucine (I) at amino acid position 39 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at